Share prices slipped after hours yesterday after AngioDynamics (NSDQ:ANGO) lowered its outlook for the rest of fiscal 2016, despite a swing to profits on better-than-expected fiscal 3rd-quarter results. Latham, N.Y.-based AngioDynamics, which ousted former president & CEO Joe DeVivo earlier this week, posted profits of $630,000, or 2¢ per share, on sales growth of 0.9% to $87.4 million […]
AngioDynamics
AngioDynamics CEO DeVivo out, ex-Covidien exec Clemmer in | Personnel Moves for April 4, 2016
1. AngioDynamics CEO DeVivo is out, ex-Covidien exec Clemmer is in AngioDynamics (NSDQ:ANGO) said today that president & CEO Joseph DeVivo stepped down to “pursue other interests” and was replaced by ex-Covidien bigwig James Clemmer, effective today. DeVivo joined Latham, N.Y.-based AngioDynamics in September 2011. “We thank Joe for his contributions and commitment to AngioDynamics over […]
AngioDynamics wins Health Canada nod for new Celerity device
AngioDynamics (NSDQ:ANGO) said today that it won approval from Health Canada for its Celerity with Navigation tip location system for peripherally inserted central catheters. Latham, N.Y.-based AngioDynamics won approval north of the border for the 1st Celerity iteration back in September 2013. The new version is designed to allow real-time catheter tracking, the company said. “This is […]
AngioDynamics must face Bard patent infringement lawsuit
AngioDynamics (NSDQ:ANGO) must face a patent infringement lawsuit brought by Bard and subsidiary Bard Peripheral Vascular, a federal judge in Delaware ruled this week. Murray Hill, N.J.-based Bard sued AngioDynamics in March 2015, alleging that its Smart Port and other implantable power-injectable port products trespass on a trio of Bard patents, according to court documents. AngioDynamics asked […]
AngioDynamics slumps on Q2 rev, EPS misses
AngioDynamics (NSDQ:ANGO) saw shares slump as it reported 2nd quarter earnings that missed analysts marks and shrunk from its previous year. AngioDynamics reported losses of $362,000, or 1¢ per share, on sales of $89.2 million for the 3 months ended Nov. 30. That amounts to a 127% slide on profits as it saw sales shrink 3.2% […]
FDA lifts final warning letters for AngioDynamics
AngioDynamics (NSDQ:ANGO) said today that the FDA closed out a pair of warning letters sent in 2011 and 2014, closing the book on all warning letters sent to the Latham, N.Y.-based medical device company. The federal safety watchdog last month resolved another warning letter sent to AngioDynamics in January 2011 over the NanoKnife tissue ablation device. AngioDynamics said the FDA […]
Biolitec loses Supreme Court bid to overturn $75m contempt ruling
German medical laser maker Biolitec (ETR:BIB) today lost its bid to have the U.S. Supreme Court review an appeals court decision upholding a $75 million contempt penalty in its longtime legal dispute with AngioDynamics (NSDQ:ANGO). Judge Michael Ponsor of the U.S. District Court for Massachusetts slapped Biolitec with a $75 million contempt ruling last year, after finding that it deliberately […]
FDA closes out AngioDynamics NanoKnife warning letter
AngioDynamics (NSDQ:ANGO) said today it received a notice from the FDA closing out a warning letter it received in January 2011 in relation to its NanoKnife system. The Albany, N.Y.-based company’s NanoKnife system uses high-voltage, low-energy electrical pulses which AngioDynamics said can permanently open pores in cell membranes. The company received a warning in 2011 over allegedly […]
Angiodynamics CFO Frost resigns, moves to Analogic | Personnel Moves
AngioDynamics (NSDQ:ANGO) said today its CFO and exec veep Mark Frost resigned from his position to join Analogic (NSDQ:ALOG) as senior veep, treasurer & CFO. AngioDynamic’s veep and global controller Michael Trimach will serve as Interim CFO as the company searches for a permanent replacement. The Albany, N.Y.-based company said Frost will stay on to facilitate a smooth […]
AngioDynamics wins S. Korean approval for NanoKnife
AngioDynamics (NSDQ:ANGO) said today it won approval from South Korea’s Ministry of Food and Drug Safety for its NanoKnife system designed to ablate soft tissue. The NanoKnife system uses high-voltage, low-energy electrical pulses which AngioDynamics said can permanently open pores in cell membranes. “As we discussed in our recent earnings call, we have been aggressively registering NanoKnife […]
Angiodynamics slides on Q1 earnings, rev misses
AngioDynamics (NSDQ:ANGO) reported a weak 1st quarter, seeing shrinking revenue and earnings that missed the street’s expectations. Angiodynamics reported losses of $757,000, or 2¢ per share, on sales of $83.7 million for the 3 months ended August 31. That amounts to a 261% slide on the bottom-line with sales shrinking 4.2% compared with the same period […]